Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Enzyme controls ’good cholesterol’

27.02.2003


A recently discovered enzyme called endothelial lipase regulates the structure, metabolism and blood concentration of high density lipoprotein (HDL), the so-called "good cholesterol," said researchers from Baylor College of Medicine in a report in the online version of the Proceedings of the National Academy of Sciences.



In a series of studies in mice, Dr. Lawrence Chan, chief of the section of endocrinology and metabolism at Baylor, his co-workers and colleagues from the section of cardiology and atherosclerosis have found that when mice lack this enzyme, the particles of HDL in their blood are much larger than normal.

"We don’t know if it is good or bad that the HDL becomes larger," said Chan. "We were always taught that high levels of HDL are good for you because HDL carries cholesterol from the outer areas of the body back to the liver where it is excreted as bile."


High levels of HDL may also inhibit inflammation, a newly accepted factor in coronary heart disease, Chan said.

"It also protects the vascular wall," he said. "It may also slow down the oxidation of low density lipoprotein (the so-called bad cholesterol). Oxidized LDL is very bad."

A variant of the enzyme that is found in approximately 26 percent of people is associated with high levels of HDL, he said. He and his colleagues are studying the fate of patients with this type of enzyme to determine whether it is beneficial or not.

Once they determine whether the variant form of HDL is good or bad, it can become a target for drug developers who will attempt to manipulate levels of "good" cholesterol through this mechanism.

One concern is that the larger particles of HDL might slow the transport of cholesterol back to the liver, which probably would not be good, said Chan. While HDL might have all the good actions including working against inflammation and protecting the vascular wall, that would have to be balanced against the interruption of cholesterol transport to the liver.

In his experiments, he found that metabolism of HDL is a lot slower without the enzyme.

"That’s why the concentration goes up as the HDL accumulates," he said.

Others who participated in the study included Drs. Ke Ma, Mehmet Cilingiroglu, Christie M. Ballantyne and Ali J. Marian, all of Baylor, and Dr. James Otvos of LipoScience of Raleigh, NC.

Anissa Anderson Orr | EurekAlert!
Further information:
http://research.bcm.tmc.edu/

More articles from Life Sciences:

nachricht Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology

nachricht Mapping immune cells in brain tumors
29.05.2020 | University of Zurich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Black nitrogen: Bayreuth researchers discover new high-pressure material and solve a puzzle of the periodic table

29.05.2020 | Materials Sciences

Argonne researchers create active material out of microscopic spinning particles

29.05.2020 | Materials Sciences

Smart windows that self-illuminate on rainy days

29.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>